Article

Retinal detachment highly treatable due to latest approaches, according to study

Although retinal detachments puts an individual at risk for vision loss or blindness, a new study published in the New England Journal of Medicine showed that a high probability of reattachment and visual improvement is possible by using one of the three currently available surgical techniques.

New York-Although retinal detachments puts an individual at risk for vision loss or blindness, a new study published in the New England Journal of Medicine showed that a high probability of reattachment and visual improvement is possible by using one of the three currently available surgical techniques.

"Although no randomized trials have been conducted that show definitively that one procedure is best for every situation, improvements in these surgical techniques have led to effective treatments for most patients," said lead author Donald J. D'Amico, MD, New York-Presbyterian Hospital, Weill Cornell Medical Center and Weill Cornell Medical College, New York.

In the article, Dr. D'Amico offers his recommendations for treating a man aged 57 years who experiences sudden flashes and floaters in one eye, progressive loss of vision, and a retinal detachment. Currently the three surgical options in use to treat such a case are:

• Scleral Buckling Surgery-According to Dr. D'Amico, scleral buckling is a relatively involved procedure and requires the use of a hospital operating room. It is usually performed on an outpatient basis with local anaesthesia with intravenous sedation, and the overall success rate for reattachment is about 90%.

• Pneumatic Retinopexy-This less invasive procedure is not suitable for every patient and has a somewhat lower success rate with initial treatment than does scleral buckling or vitrectomy, said Dr. D'Amico. Nevertheless, because of its minimally invasive attributes, and the fact that an attempted pneumatic does not reduce the ultimate chance for success if additional surgery is required for recurrent detachment, patient and surgeons increasingly select pneumatic retinopexy.

• Vitrectomy-Dr. D'Amico notes that there is a very strong shift toward vitrectomy, and away from buckling particularly by younger surgeons and for patients that have detachment after cataract surgery. Vitrectomy for detachment may be associated with a higher risk of postoperative cataract, and this appears to be its main disadvantage compared with buckling, which has lower risk of cataract but higher risk of other complications. In cases where bleeding in the vitreous gel is present with the detachment, a vitrectomy approach is clearly preferred to remove the vitreous hemorrhage in order to gain better visualization to find and repair tears or holes in the retina. Vitrectomy, like scleral buckling, is typically done on an outpatient basis with local anaesthesia with intravenous sedation.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.